SYNERGY BETWEEN RS1049296 IN TRANSFERRIN AND RS1800562 IN HEMOCHROMATOSIS AS A RISK FACTOR FOR ALZHEIMER’S DISEASE

Elizabeth Vance; Lyndsay Staley; Paul K. Crane; Shubhabrata Mukherjee; John Kauwe; ADGC

首页> 外文期刊>Alzheimer’s & dementia: the journal of the Alzheimer’s Association >SYNERGY BETWEEN RS1049296 IN TRANSFERRIN AND RS1800562 IN HEMOCHROMATOSIS AS A RISK FACTOR FOR ALZHEIMER’S DISEASE

【24h】

SYNERGY BETWEEN RS1049296 IN TRANSFERRIN AND RS1800562 IN HEMOCHROMATOSIS AS A RISK FACTOR FOR ALZHEIMER’S DISEASE

机译：转铁蛋白的RS1049296与血色瘤症RS1800562之间的协同作用，作为阿尔茨海默病的危险因素

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Alzheimer’s & dementia: the journal of the Alzheimer’s Association 》 |2018年第7期| 共2页
作者
Elizabeth Vance; Lyndsay Staley; Paul K. Crane; Shubhabrata Mukherjee; John Kauwe; ADGC;
展开▼
作者单位

Brigham Young University;

Brigham Young University;

University of Washington;

University of Washington;

Brigham Young University;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类神经病学与精神病学 ;
关键词

相似文献

外文文献
中文文献
专利

1. SYNERGY BETWEEN RS1049296 IN TRANSFERRIN AND RS1800562 IN HEMOCHROMATOSIS AS A RISK FACTOR FOR ALZHEIMER’S DISEASE [J] . Elizabeth Vance, Lyndsay Staley, Paul K. Crane, Alzheimer’s & dementia: the journal of the Alzheimer’s Association . 2018 ,第7期

机译：转铁蛋白的RS1049296与血色瘤症RS1800562之间的协同作用，作为阿尔茨海默病的危险因素
2. Effects of hemochromatosis and transferrin gene mutations on iron dyshomeostasis, liver dysfunction and on the risk of Alzheimer's disease [J] . GiambattistelliF., BucossiS., SalustriC., Neurobiology of Aging: Experimental and Clinical Research . 2012 ,第8期

机译：血色素沉着病和转铁蛋白基因突变对铁动态异常，肝功能障碍和阿尔茨海默氏病风险的影响
3. Is hemochromatosis a risk factor for Alzheimer's disease? [J] . Connor JR, Moalem S, Boyer P, Journal of Alzheimer's disease: JAD . 2001 ,第5期

机译：血色素沉着病是阿尔茨海默氏病的危险因素吗？
4. Analysis on Risk Factors of Women in Alzheimer’s Disease [C] . Xinlu Wang International Conference on Public Health and Data Science . 2020

机译：阿尔茨海默病妇女危险因素分析
5. The novel use of recombinant granulocyte-macrophage colony stimulating factor (GM-CSF) to reverse cerebral amyloidosis and cognitive impairment in Alzheimer's disease mouse models: Insights from the investigation of Rheumatoid arthritis as a negative risk factor for Alzheimer's disease [D] . Boyd, Timothy David 2010

机译：重组粒细胞巨噬细胞集落刺激因子（GM-CSF）在阿尔茨海默氏病小鼠模型中逆转脑淀粉样变性和认知障碍的新用途：类风湿关节炎作为阿尔茨海默氏病的阴性危险因素研究的启示
6. Synergy between the C2 allele of transferrin and the C282Y allele of the haemochromatosis gene (HFE) as risk factors for developing Alzheimers disease [O] . K Robson, D Lehmann, V Wimhurst, 2004

机译：转铁蛋白的C2等位基因与血色素沉着病基因（HFE）的C282Y等位基因之间的协同作用是发展阿尔茨海默氏病的危险因素
7. Failure to detect synergy between variants in transferrin and hemochromatosis and Alzheimer's disease in large cohort [O] . Elizabeth Vance, Josue D. Gonzalez Murcia, Justin B. Miller, 2020

机译：在大队列中未能检测转运素和血细胞瘤的变异和阿尔茨海默病的协同作用

SYNERGY BETWEEN RS1049296 IN TRANSFERRIN AND RS1800562 IN HEMOCHROMATOSIS AS A RISK FACTOR FOR ALZHEIMER’S DISEASE

著录项

相似文献

相关主题

期刊订阅